| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:1558137 | 6480464 | Dinitrochlorobenzene results in increased expression of ERCC6L mRNA | CTD | PMID:18242016 |
| 17beta-estradiol | increases expression | ISO | RGD:1606557 | 6480464 | Estradiol results in increased expression of ERCC6L mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | increases expression | ISO | RGD:1606557 | 6480464 | Estradiol results in increased expression of ERCC6L mRNA | CTD | PMID:19167446 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1606557 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ERCC6L mRNA | CTD | PMID:21802500 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ERCC6L mRNA | CTD | PMID:22298810 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1558137 | 6480464 | Methylcholanthrene results in increased expression of ERCC6L mRNA | CTD | PMID:20713471 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:1558137 | 6480464 | Oxazolone results in increased expression of ERCC6L mRNA | CTD | PMID:18242016 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1558137 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of ERCC6L mRNA | CTD | PMID:19191707 |
| aflatoxin B1 | affects expression | ISO | RGD:1606557 | 6480464 | Aflatoxin B1 affects the expression of ERCC6L protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1606557 | 6480464 | Aflatoxin B1 results in increased expression of ERCC6L mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | decreases expression | ISO | RGD:1558137 | 6480464 | Aflatoxin B1 results in decreased expression of ERCC6L mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1606557 | 6480464 | Benzo(a)pyrene results in decreased expression of ERCC6L mRNA | CTD | PMID:21802500 |
| calcitriol | multiple interactions | ISO | RGD:1606557 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ERCC6L mRNA | CTD | PMID:21592394 |
| calcitriol | decreases expression | ISO | RGD:1606557 | 6480464 | Calcitriol results in decreased expression of ERCC6L mRNA | CTD | PMID:21592394 |
| choline | multiple interactions | ISO | RGD:1558137 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ERCC6L mRNA | CTD | PMID:20938992 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1606557 | 6480464 | Copper Sulfate results in decreased expression of ERCC6L mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:1606557 | 6480464 | Coumestrol results in increased expression of ERCC6L mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1606557 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA; more ... | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:1606557 | 6480464 | Cyclosporine results in decreased expression of ERCC6L mRNA | CTD | PMID:19159671 |
| diethyl maleate | increases expression | EXP | | 6480464 | diethyl maleate results in increased expression of ERCC6L mRNA | CTD | PMID:21161181 |
| dioxygen | decreases expression | ISO | RGD:1606557 | 6480464 | Oxygen deficiency results in decreased expression of ERCC6L mRNA | CTD | PMID:17175027 |
| folic acid | multiple interactions | ISO | RGD:1558137 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ERCC6L mRNA | CTD | PMID:20938992 |
| L-methionine | multiple interactions | ISO | RGD:1558137 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ERCC6L mRNA | CTD | PMID:20938992 |
| lucanthone | decreases expression | ISO | RGD:1606557 | 6480464 | Lucanthone results in decreased expression of ERCC6L mRNA | CTD | PMID:21148553 |
| manganese atom | decreases expression | ISO | RGD:1606557 | 6480464 | Manganese results in decreased expression of ERCC6L mRNA | CTD | PMID:17175027 |
| manganese(0) | decreases expression | ISO | RGD:1606557 | 6480464 | Manganese results in decreased expression of ERCC6L mRNA | CTD | PMID:17175027 |
| manganese(II) chloride | decreases expression | ISO | RGD:1606557 | 6480464 | manganese chloride results in decreased expression of ERCC6L mRNA | CTD | PMID:17175027 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of ERCC6L mRNA | CTD | PMID:19041683 |
| paracetamol | increases expression | ISO | RGD:1606557 | 6480464 | Acetaminophen results in increased expression of ERCC6L mRNA | CTD | PMID:22230336 |
| phenobarbital | affects expression | ISO | RGD:1558137 | 6480464 | Phenobarbital affects the expression of ERCC6L mRNA | CTD | PMID:23091169 |
| pirinixic acid | multiple interactions | ISO | RGD:1558137 | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of ERCC6L mRNA | CTD | PMID:20813756 |
| pirinixic acid | increases expression | ISO | RGD:1558137 | 6480464 | pirinixic acid results in increased expression of ERCC6L mRNA | CTD | PMID:20813756 |
| quercetin | decreases expression | ISO | RGD:1606557 | 6480464 | Quercetin results in decreased expression of ERCC6L mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1606557 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA | CTD | PMID:19167446 |
| sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of ERCC6L mRNA | CTD | PMID:22110744 |
| testosterone | multiple interactions | ISO | RGD:1606557 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ERCC6L mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:1606557 | 6480464 | Testosterone results in decreased expression of ERCC6L mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:1558137 | 6480464 | Carbon Tetrachloride results in increased expression of ERCC6L mRNA | CTD | PMID:17484886 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:1558137 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of ERCC6L mRNA | CTD | PMID:18242016 |
| trans-resveratrol | multiple interactions | ISO | RGD:1606557 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | ISO | RGD:1558137 | 6480464 | trimellitic anhydride results in increased expression of ERCC6L mRNA | CTD | PMID:19042947 |